Cefiderocol for treating severe drug-resistant gram-negative bacterial infections (HTE2)Product type:GuidanceProgramme:Health technology evaluationPublished: 17 August 2022
Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections (HTE1)Product type:GuidanceProgramme:Health technology evaluationPublished: 17 August 2022